Antiemetics Market Share 2021 Growth Challenges, Opportunities and Future Trends 2027
The global antiemetics market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Antiemetics are therapeutic agents that are used for the effective treatment of nausea and vomiting. Nausea and vomiting are the symptoms of several medical conditions such as motion sickness, dizziness, pregnancy, emotional stress and food poisoning. Additionally, antiemetics drugs are also used for the treatment of the side effects of other medications such as opioid analgesics, chemotherapy and general anaesthetics.
The major factor for the growth of the market is the
increasing geriatric population along with the growing prevalence of cancer as
well as the growing number of gastroenteritis patients. The market is also
driven by extensive R&D along with new FDA approvals. For instance, in
April 2021, Caplin Steriles has been granted final approval from the US FDA for
its abbreviated new drug application (ANDA) prochlorperazine edisylate
injection USP, 10 mg/2 mL (5 mg/mL) vials. Prochlorperazine edisylate injection
is an antiemetic drug that is indicated for the control of severe nausea and
vomiting.
To Request a Sample of our Report on Antiemetics Market: https://www.omrglobal.com/request-sample/antiemetics-market
The global antiemetics market
is anticipated to grow at a significant CAGR during the forecast period
(2021-2027). Antiemetics are therapeutic agents that are used for the effective
treatment of nausea and vomiting. Nausea and vomiting are the symptoms of several
medical conditions such as motion sickness, dizziness, pregnancy, emotional
stress and food poisoning. Additionally, antiemetics drugs are also used for
the treatment of the side effects of other medications such as opioid
analgesics, chemotherapy and general anaesthetics.
The major factor for the growth of the market is the
increasing geriatric population along with the growing prevalence of cancer as
well as the growing number of gastroenteritis patients. The market is also
driven by extensive R&D along with new FDA approvals. For instance, in
April 2021, Caplin Steriles has been granted final approval from the US FDA for
its abbreviated new drug application (ANDA) prochlorperazine edisylate
injection USP, 10 mg/2 mL (5 mg/mL) vials. Prochlorperazine edisylate injection
is an antiemetic drug that is indicated for the control of severe nausea and
vomiting.
(Get 15% Discount on Buying this Report)
A
full Report of Antiemetics Market is Available @ https://www.omrglobal.com/industry-reports/antiemetics-market
Global Antiemetics Market Report by Segment
By
Drug Class
• 5-HT3 receptor antagonists
• Anticholinergics
• Benzodiazepines
• Cannabinoids
• Others
By
Application
• Chemotherapy
• Gastroenteritis
• General anaesthetics
• Pregnancy
• Others
Global
Antiemetics Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment